<span>Three common myths about flu shots for employees</span>
October 20, 2022

Three common myths about flu shots for employees

Heading into spring, it may seem as though any thoughts of the flu should be gone with the winter’s frost. However, while we are less likely to contract the flu, there is no time like the present to prepare for its inevitable return this fall.
<span>Labcorp receives emergency use authorization for first non-prescription at-home collection kit for combined COVID-19, flu and RSV detection</span>
May 18, 2022

Labcorp receives emergency use authorization for first non-prescription at-home collection kit for combined COVID-19, flu and RSV detection

BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often seen in children.
<span>Labcorp receives Emergency Use Authorization for at-home collection kit for combined COVID-19 and flu detection</span>
October 1, 2021

Labcorp receives Emergency Use Authorization for at-home collection kit for combined COVID-19 and flu detection

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined home collection kit that detects COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with COVID-19 or if asked to be tested by a health care provider.